Jan 22 (Reuters) - Shilpa Medicare Ltd:
* US FDA COMPLETED INSPECTION OF COâ€˜S API FACILITIES UNIT-I AND UNIT-II LOCATED AT RAICHUR, KARNATAKA
* SAYS INSPECTION CLOSED BY US FDA WITH THREE 483 OBSERVATIONS
* IN PROCESS OF SUBMISSION OF CAPA PLAN TO REGULATOR WITHIN STIPULATED TIMELINES IN RESPONSE TO FORM 483 ISSUED Source text - bit.ly/2F0R0U9 Further company coverage:
 